Andrew Arbuckle-Lockwood is a medical device technology consultant with experience in both neurology and digital health. Andrew is based in Denver, Colorado, and works for Rune Labs, a Silicon Valley-based company focused on building tools to help those living with Parkinson's Disease and other neurodegenerative conditions. Rune Lab's digital health product, StrivePD, works directly with the Apple Watch and Medtronic's DBS implant to objectively track Parkinson's symptoms, provide critical insight into daily patterns that might improve the patient's condition, and enhance communication between patients and their care teams. StrivePD is currently available free of charge in the Apple App Store! Andrew will be speaking at the monthly meeting on Friday, January 19th.
Medical Device Technology Consultant,
Debra Wasson graduated with a Bachelor's degree from Brigham Young University in Community Health Education. She has worked and volunteered for multiple profit and non-profit organizations to promote health and wealthiness. Her mother, who lives out of state, was diagnosed with Parkinson’s disease in 2019. Because Debra does not live to close to her mother, she wants to serve others with the disease. Debra is married with 3 adult children, and has lived in the Austin area since 2007.
Choose CAPS as your AmazonSmile charity to help your dollar stretch farther and support the Parkinson's community. All AmazonSmile donations go directly toward support services such as individual & group respite, family financial assistance, groceries, transportation, medication, and so much more.
Randall’s Good Neighbor program contributes 1% of your purchases to CAPS when you choose us as your designated nonprofit. Just email email@example.com with your Randall’s For U account phone number and CAPS’ account number 11720.
In 2023, FDA 510(k) clearance will expand the reach of Rune Labs' platform to help millions who currently have or are at risk of developing Parkinson's disease.
The American Parkinson Disease Association (APDA) will fund multiple Parkinson's Disease research projects in 2023. The funding package totals $2.35 million, and will include projects studying a treatment for freezing of gait and examining the molecular underpinnings of anxiety.